BROADWOOD CAPITAL INC
Q2 2026 Form 13-F
NEW YORK, NEW YORK
CIK 0001278387
· CRD 159286
· SEC-registered investment adviser
Consolidated report · includes
1 manager
since Q2 2013
$1.9B Reported Value Total
BROADWOOD CAPITAL, INC reports 1 total accounts under management (AUM). There are 1 discretionary accounts valued at $1,711,394,203, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
1 fund
· $1.7B gross asset value
Hedge Fund: $1.7B
Source: Form ADV filed 2026-03-31
Reported value
$1.9B
Quarter over quarter
+34.5%
Holdings
6
Top-10 concentration
100.0%
Filing Structure
Reports holdings for
- BROADWOOD PARTNERS L P · File #028-13770 · since Q2 2013
Key People
Form ADV owners & control persons
Neal Clifton Bradsher
PRESIDENT / CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 14, 2026 |
| Form | 13F-HR |
| Reported value | $1.9B |
| Positions | 6 |
| Change in reported value | +34.9% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 14, 2026
|
6 | $1.9B |
|
Q1 2026 13F
Filed May 15, 2026
|
6 | $1.4B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
7 | $1.7B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
7 | $1.7B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
8 | $1.6B |
|
Q1 2025 13F
Filed May 15, 2025
|
8 | $1.2B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
7 | $1.3B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
7 | $1.3B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
7 | $1.3B |
|
Q1 2024 13F
Filed May 15, 2024
|
7 | $1.3B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
7 | $1.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
7 | $1.1B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
7 | $1.3B |
|
Q1 2023 13F
Filed May 15, 2023
|
7 | $1.4B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
7 | $1.2B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
8 | $1.3B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
8 | $1.3B |
|
Q1 2022 13F
Filed May 16, 2022
|
7 | $1.4B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
7 | $1.6B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
7 | $2.0B |
33 earlier quarters on file — choose one from the quarter menu above.
Top 6 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MNST MONSTER BEVERAGE CORP NEW | $779.3M | 40.73% |
| 2 | STAA STAAR SURGICAL CO | $462.6M | 24.18% |
| 3 | AXON AXON ENTERPRISE INC | $388.8M | 20.32% |
| 4 | IWM ISHARES TR | $142.7M | 7.46% |
| 5 | IMDX INSIGHT MOLECULAR DIA INC | $74.8M | 3.91% |
| 6 | LCTX LINEAGE CELL THERAPEUTICS IN | $64.9M | 3.39% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.